Furthermore, Taylor et al. (2016) found an increase in BOLD activity in the primary visual cortex in DLB patients taking cholinesterase inhibitors compared to those patients not on this medication, indicating that the loss of inhibition of visual areas might be modulated by the cholinergic system. The gene discussed is BCHE; the disease is Lewy body dementia.